首页> 外国专利> AUTOMATIC REVIEW OF PHARMACEUTICAL PRESCRIPTIONS FOR A PATIENT

AUTOMATIC REVIEW OF PHARMACEUTICAL PRESCRIPTIONS FOR A PATIENT

机译:自动审查患者的药物处方

摘要

The invention relates to the creation and/or optimization of a medical prescription plan for at least one patient, wherein the method according to the invention comprises: acquiring primary prescription data for the at least one patient, wherein the primary prescription data comprises a primary pharmaceutical identification; determining a blisterability parameter for the at least one pharmaceutical. The determination of the blisterability parameter comprises: a primary availability check for evaluating an availability data set as to whether the primary pharmaceutical identification is present in the availability data set; and assigning a first value to the blisterability parameter or an equivalence check, depending on whether the primary pharmaceutical identification is present in the availability data set or not. To this end, the equivalency check comprises: determining an equivalence data set from an equivalence database such that the equivalence data set at least partially comprises pharmaceutical identifications that are associated with the primary pharmaceutical identification by the equivalence data bank; a secondary availability check for evaluating the availability data set as to whether at least one pharmaceutical identification of the equivalence data set is present in the availability data set; and assigning a second value or a third value to the blisterability parameter, depending on whether at least one pharmaceutical identification of the equivalence data set is present in the availability data set or not. A blisterability indicator is issued with respect to the primary pharmaceutical identification and as a function of the assigned value of the blisterability parameter.
机译:本发明涉及至少一个患者的医疗处方计划的创建和/或优化,其中根据本发明的方法包括:获取至少一个患者的主要处方数据,其中主要处方数据包括主要药物鉴定确定至少一种药物的起泡性参数。起泡性参数的确定包括:初级可用性检查,用于评估关于可用性数据集中是否存在初级药物标识的可用性数据集;以及并根据可获得性数据集中是否存在主要药物标识,为起泡性参数或等效性检查分配一个第一值。为此,等效性检查包括:从等效性数据库确定等效性数据集,以使得等效性数据集至少部分地包括与等效性数据库的主要药品标识相关联的药品标识;以及二次可用性检查,用于评估可用性数据集,以关于可用性数据集中是否存在至少一个等效数据集的药物标识;根据所述可得性数据集中是否存在所述当量数据集的至少一种药物标识,为所述起泡性参数分配第二值或第三值。根据主要药物标识并根据起泡性参数的分配值发出起泡性指示剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号